<DOC>
	<DOCNO>NCT01080573</DOCNO>
	<brief_summary>This 1-arm , open-label , multicentric , observational study aim collect subject centric information line routine care . Subjects ' expectation therapy , side effect management lifestyle may influence adherence therapy . This survey aim determine whether factor and/or others affect successful initiation maintenance Rebif therapy . The data collect study include information subject 's treatment include expectation , experience , train support . The result study used understand impact subject ' compliance tailor train support service subject 's need . It also make available healthcare organisation involve subject treatment .</brief_summary>
	<brief_title>Rebif Compliance Support Program - Assessing Needs Multiple Sclerosis</brief_title>
	<detailed_description>Multiple sclerosis ( MS ) chronic , inflammatory , demyelinate disease central nervous system one common cause neurological disability young adult . It characterise multifocal , recurrent attack neurological symptom sign variable recovery . Eventually majority subject develop progressive clinical course . It important carefully initiate maintain subject MS therapy . Information gather structured way enable easy identification subgroup subject may risk poor compliance . These risk group could possibly include group particular attribute poor information start treatment , unrealistic expectation particular life style . This study conduct contact subject necessary deliver homecare service . Participants contact Bupa Home Healthcare Multiple Sclerosis subject coordinator telephone conduct specific questionnaires 4 stage subject 's treatment i.e . pre-installation treatment , post installation treatment , monthly pre delivery drug subject 's end treatment . OBJECTIVES - To collect subject centric information line routine care include subject 's expectation therapy , side effect management lifestyle may influence adherence therapy - To determine whether factor and/or others affect successful initiation maintenance Rebif therapy</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Subjects prescribe Rebif refer Bupa Home Healthcare service one participate refer centre Subject unwilling give inform consent Subjects visit private clinic</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Rebif</keyword>
	<keyword>Interferon beta-1a</keyword>
</DOC>